Article
Biomarkers for the Management of Cholangiocarcinoma: Unveiling New Horizons for Precision Therapy
2025-01-23
Abstract excerpt
Cholangiocarcinoma (CCA) is an aggressive malignancy with limited methods for early detection, necessitating the development of reliable biomarkers for diagnosis and management. However, conventional tumor markers, such as CA19-9 and CEA, exhibit insufficient diagnostic accuracy. Recent advancements in molecular genetics have identified several actionable mutations in CCA, enabling molecularly targeted therapies t...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a2cdc8c4-f233-52c5-92b6-5ed9cac047ea
- DOI
- 10.20944/preprints202501.1720.v1
